Akcea Therapeutics Inc. (NASDAQ: AKCA) stock jumped on Monday after it was announced that Ionis Pharmaceuticals Inc. (NASDAQ: IONS) would be acquiring all of its outstanding shares.
Under the terms of the deal, Ionis will acquire the shares for $18.15, which corresponds to a total transaction value of approximately $500 million on a fully diluted basis. The transaction is expected to be funded through existing cash resources.
Also, this transaction has been approved by both the Ionis and Akcea boards of directors and is expected to close in the fourth quarter of 2020.
Ultimately, the deal will help Ionis realize more financial upside from Akcea’s pipeline and commercial products. Accordingly, Ionis will gain full access to Akcea’s significant cash on hand of roughly $390 million and future cash flows to further invest in the company’s future and further support Ionis’ capital allocation strategy.
Akcea management noted that this transaction delivers immediate and certain value with a premium to Akcea shareholders. The close collaboration with Ionis has been key to enabling the launch of two commercial antisense medicines in just two years, as well as advancing a late-stage pipeline and securing important partnerships.
Accordingly, Akcea shareholders are getting a solid premium from this buyout. The 50-day and 200-day moving averages imply premiums of 44.3% and 16.5%, respectively.
Akcea stock traded up about 60% Monday morning, at $18.19 in a 52-week range of $8.00 to $22.79. The consensus price target is $27.00.
Ionis stock was up 2% to $53.92, in a 52-week range of $39.32 to $67.31. The consensus price target is $68.11.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
